drugset / Trial / NCT07463430

Suzetrigine for Non-Mastectomy Breast Surgery

NCT07463430

NaSingle-groupOpen-labelTreatment

Summary

This is a single-center clinical study to investigate the efficacy of a Food and Drug Administration-approved analgesic, suzetrigine, to treat pain following non-mastectomy breast surgery in concert with a single-injection paravertebral nerve block.

Timeline

Start
2026-04-14
Primary completion
2027-12-28
Completion
2027-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Suzetrigine Small molecule 50 mg Oral

Indications